Cargando…

Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach

ABSTRACT: Parkinson’s disease is a neurodegenerative disorder characterized by slow movement, tremors, and stiffness caused due to loss of dopaminergic neurons caused in the brain’s substantia nigra. The concentration of dopamine is decreased in the brain. Parkinson’s disease may be happened because...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baweja, Gurkaran Singh, Gupta, Shankar, Kumar, Bhupinder, Patel, Preeti, Asati, Vivek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047469/ https://www.ncbi.nlm.nih.gov/pubmed/36977955 http://dx.doi.org/10.1007/s11030-023-10634-6

Ejemplares similares

A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023
por: Ipe, Reshma Susan, et al.
Publicado: (2023)

Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
por: Finberg, John P. M., et al.
Publicado: (2016)

MAO-inhibitors in Parkinson's Disease
por: Riederer, Peter, et al.
Publicado: (2011)

Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
por: Hagenow, Jens, et al.
Publicado: (2020)

New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
por: Pacureanu, Liliana, et al.
Publicado: (2023)

Maó
por: Quintana, Josep M. (Josep Maria)
Publicado: (1996)

Therapeutic Approaches in Pancreatic Cancer: Recent Updates
por: Kumar, Lokender, et al.
Publicado: (2023)

Mao : a biography /
por: Terrill, Ross
Publicado: (1981)

Mao Zedong
por: Grimm, Tilemann
Publicado: (1986)

Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disorder
por: Kumar, Sunil, et al.
Publicado: (2023)

Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer
por: Bardaweel, Sanaa, et al.
Publicado: (2022)

PLATELET MAO ACTIVITY IN CHRONIC SCHIZOPHRENIA
por: Gupta, A.K., et al.
Publicado: (1985)

Mao Tse-Tung
por: Payne, Robert
Publicado: (1972)

Mao Tse-tung
por: MacGregor-hastie, Roy

Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions
por: Kitanaka, Junichi, et al.
Publicado: (2006)

The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells
por: Zarmouh, Najla O., et al.
Publicado: (2020)

PLATELET MAO ACTIVITY IN SUBGROUPS OF SCHIZOPHRENIA
por: Sharma, I., et al.
Publicado: (1990)

CLINICAL VARIABLES AND PLATELET MAO IN SCHIZOPHRENIA
por: Sharma, Indira, et al.
Publicado: (1991)

EFFECT OF IMIPRAMINE AND ECT ON PLATELET MAO ACTIVITY IN DEPRESSIVES
por: Trivedi, J.K., et al.
Publicado: (1989)

Changes of MAO-A and MAO-B Expressions in the Placenta of MPTP or MPP(+) Treated Mice
por: Sai, Takafumi, et al.
Publicado: (2013)

Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain
por: Fowler, Joanna S, et al.
Publicado: (2015)

Mao Tse-Tung : un revolucionario
por: Payne, Pierre Stephen Robert, 1911-
Publicado: (1965)

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy
por: Lecht, Shimon, et al.
Publicado: (2007)

Monoamine oxidase A (MAO A) inhibitors decrease glioma progression
por: Kushal, Swati, et al.
Publicado: (2016)

A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease
por: Jost, Wolfgang H.
Publicado: (2022)

Structure-Based Design of Novel MAO-B Inhibitors: A Review
por: Mateev, Emilio, et al.
Publicado: (2023)

La economía según Mao /
por: Saltiel, Jean Pierre
Publicado: (1972)

The poems of Mao Tse-tung
por: Mao, Zedong, 1893-1976
Publicado: (1972)

Los comics de Mao
Publicado: (1976)

Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis
por: Cho, Hyun-U, et al.
Publicado: (2021)

Apocalipsis Mao : el último emperador cumple 100 años /
por: Leguineche, Manuel
Publicado: (1993)

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches
por: Zheng, Linfeng, et al.
Publicado: (2022)

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease
por: Park, Jong-Hyun, et al.
Publicado: (2019)

Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease
por: Krishna, Rakhee, et al.
Publicado: (2014)

Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors
por: Sairam, Kalapatapu V.V.M., et al.
Publicado: (2007)

Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors
por: Ilgın, Sinem, et al.
Publicado: (2017)

Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors
por: Osmaniye, Derya, et al.
Publicado: (2021)

Coumarin-Chalcone Hybrids as Inhibitors of MAO-B: Biological Activity and In Silico Studies
por: Moya-Alvarado, Guillermo, et al.
Publicado: (2021)

Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors
por: Gogineni, Vedanjali, et al.
Publicado: (2021)

Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors
por: Alagöz, Mehmet Abdullah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmoqb7el74jhh86a4f9tisafuq